RF
67
-2
FLR
48
-2
PNW
66
3
TRV
52
3
NWS
69
9
INTC
40
-3
LMT
29
-8
CSCO
60
2
ETN
50
-7
WM
76
3
IP
60
-5
ABT
62
2
EMR
47
-3
DLTR
48
4
TXT
62
3
MSI
47
-2
GM
63
-8
KO
65
10
TSN
52
6
MTCH
35
9
RF
67
-2
FLR
48
-2
PNW
66
3
TRV
52
3
NWS
69
9
INTC
40
-3
LMT
29
-8
CSCO
60
2
ETN
50
-7
WM
76
3
IP
60
-5
ABT
62
2
EMR
47
-3
DLTR
48
4
TXT
62
3
MSI
47
-2
GM
63
-8
KO
65
10
TSN
52
6
MTCH
35
9
Financhill
Back

Janux Therapeutics 10K Form

Sell
44

JANX
Janux Therapeutics

Last Price:
$29.72
Seasonality Move:
3.51%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive JANX News And Ratings

See the #1 stock for the next 7 days that we like better than JANX

JANX Financial Statistics

Sales & Book Value

Annual Sales: $10.6M
Cash Flow: $-16.8M
Price / Cash Flow: 0
Annual Sales: $17.32
Price / Book: 1.74

Profitability

EPS (TTM): -1.28000
Net Income (TTM): $-69M
Gross Margin: --
Return on Equity: -11.37%
Return on Assets: -10.65%

Janux Therapeutics Earnings Forecast

Key Janux Therapeutics Financial Ratios

  • The Research & Development expenses have been 645.90% of Revenue.
  • The Net Earning history of JANX is -651.62% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 3 years.

Janux Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: JANX
Website: januxrx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 38.8
Quick Ratio: 38.58

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

JANX Technical Analysis vs Fundamental Analysis

Sell
44
Janux Therapeutics (JANX) is a Sell

Is Janux Therapeutics a Buy or a Sell?